| Model: | Ratio |
| Symbol | Title | Sector | Industry | M.Cap.[M] | Div Yield | Last Close | AvgVol 200d |
| GSK | GlaxoSmithKline PLC ADR | Healthcare | Drug Manufacturers - General | 88364 | 0.0381 | 43.24 | 5173719 |
| NVS | Novartis AG ADR | Healthcare | Drug Manufacturers - General | 253368 | 0.0306 | 130.36 | 1839995 |
| Entry Threshold: | 2.00 | Exit Threshold: | 0.00 | ||
| Max Duration: | 20 | Entry Mode: | Uptick | Reversals: | |
| MA Period: | 15 | MA Type: | EMA | StdDev Period: | 15 |
| RSI Period: | 14 | RSI Threshold: | 0 | ||
| Margin Req. 1: | 50.0 | Margin Req. 2: | 50.0 | ||
| Version: | 5 | Model Version: | 2016.1 | Bid-Ask 0.01 / 0.01 | |
| Initial Capital: | 10000.00 | Final Equity: | 10522.23 |
| Total net P/L: | 522.23 | Total ROI: | 5.22 % |
| CAGR: | 22.93 % | Max. DD: | 2.95 % |
| System Score: | 7.981 | Sharpe Ratio: | 1.219 |
| Start Date: | 2010-04-01 | End Date: | 2010-06-30 |
| Total days: | 90 | ||
| Commissions: | 26.69 | Comm.% P/L | 4.86 % |
| Total Transactions: | 20 | Log. Linearity: | 70.342 % |
| Total | Long |
Short |
GSK | NVS | |
|---|---|---|---|---|---|
| Total Profit/Loss | 548.92 | 522.49 | 26.43 | 1167.23 | -618.31 |
| Total Profit | 557.34 | 522.49 | 34.85 | 1258.76 | 158.51 |
| Total Loss | 8.42 | 0.00 | 8.42 | 91.53 | 776.82 |
| Profit Factor | 66.23 | 0.00 | 4.14 | 13.75 | 0.20 |
| Trades | 5 | 3 | 2 | 5 | 5 |
| Winning Trades | 4 | 3 | 1 | 4 | 2 |
| Losing Trades | 1 | 0 | 1 | 1 | 3 |
| % Profitable | 80.00 | 100.00 | 50.00 | 80.00 | 40.00 |
| Profit/Loss Per Trade % | 1.08 | 1.71 | 0.13 | 2.29 | -1.25 |
| Profit Per Trade % | 1.37 | 1.71 | 0.34 | 3.10 | 0.76 |
| Loss Per Trade % | 0.08 | 0.00 | 0.08 | 0.87 | 2.56 |
| Days In Trade | 54 | 13 | 41 | 54 | 54 |
| Days In Trade (Avg. Per Trade) | 10.80 | 4.33 | 20.50 | 10.80 | 10.80 |
| % Days In Trade | 60.00 | 14.44 | 45.56 | 60.00 | 60.00 |